LNSR
LENSAR Inc (LNSR)
Healthcare • NASDAQ • $5.64+7.84%
- Symbol
- LNSR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $5.64
- Daily Change
- +7.84%
- Market Cap
- $68.27M
- Trailing P/E
- N/A
- Forward P/E
- -7.94
- 52W High
- $14.31
- 52W Low
- $5.06
- Analyst Target
- $8.50
- Dividend Yield
- N/A
- Beta
- 0.84
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Flori…
Company websiteResearch LNSR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.